EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.362
https://www.valueinhealthjournal.com/article/S1098-3015(23)00462-X/fulltext
Title : EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00462-X&doi=10.1016/j.jval.2023.03.362
First page :
Section Title :
Open access? : No
Section Order : 11742
Categories :
Tags :
Regions :
ViH Article Tags :